Kaster Tyler S, Blumberger Daniel M, Gomes Tara, Sutradhar Rinku, Wijeysundera Duminda N, Vigod Simone N
Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health, Toronto, ON, Canada.
Lancet Psychiatry. 2022 Jun;9(6):435-446. doi: 10.1016/S2215-0366(22)00077-3. Epub 2022 Apr 26.
Previous studies examining the risk of suicide death after treatment with electroconvulsive therapy have been confounded and the resulting uncertainty around the risk-benefit profile of electroconvulsive therapy might contribute to its underuse. We aimed to compare the risk of death by suicide after psychiatric hospitalisation among individuals with depression who had been exposed to electroconvulsive therapy with those who had not.
This was a propensity score-weighted, retrospective cohort study using linked population-level administrative health data for adults with depression who had been admitted to a designated psychiatric bed in Ontario, Canada for more than 3 days between April 1, 2007 and Dec 31, 2017. Electroconvulsive therapy exposure was defined as one or more physician billing procedure codes during hospitalisation. The primary outcome was death by suicide identified using administrative health records within 365 days following discharge. We used cause-specific Cox proportional hazards model to estimate the cause-specific hazard ratio (csHR) for electroconvulsive therapy-exposed and electroconvulsive therapy-unexposed individuals. Secondary outcomes were non-suicide death and all-cause mortality.
In the analytic cohort, there were 67 327 psychiatric hospitalisation records (27 231 men and 40 096 women; mean age 45·1 years [SD 16·8; range 18-103]), of whom 4982 were exposed to electroconvulsive therapy and 62 345 were not exposed to electroconvulsive therapy. No ethnicity data were available. In propensity-score weighted analyses, electroconvulsive therapy was associated with a significantly reduced risk of suicide death (csHR 0·53 [95% CI 0·31-0·92]). Accounting for non-suicide death as a competing risk had no effect on the findings. Electroconvulsive therapy was also associated with a significantly reduced risk of all-cause mortality (0·75 [0·58-0·97]), but not non-suicide death (0·83 [0·61-1·12]).
Among individuals admitted to hospital with depression, electroconvulsive therapy is associated with a significantly reduced risk of death by suicide in the year after discharge. This study reinforces the importance of electroconvulsive therapy, particularly for people with severe depression.
Norris Scholars Award, Department of Psychiatry, University of Toronto, and the Canadian Institutes for Health Research.
以往关于电休克治疗后自杀死亡风险的研究存在混淆因素,围绕电休克治疗风险效益概况的不确定性可能导致其使用不足。我们旨在比较接受电休克治疗的抑郁症患者与未接受电休克治疗的抑郁症患者在精神病住院后自杀死亡的风险。
这是一项倾向评分加权的回顾性队列研究,使用加拿大安大略省2007年4月1日至2017年12月31日期间入住指定精神病床位超过3天的成年抑郁症患者的关联人群水平行政健康数据。电休克治疗暴露定义为住院期间一个或多个医生计费程序代码。主要结局是出院后365天内使用行政健康记录确定的自杀死亡。我们使用特定病因的Cox比例风险模型来估计接受电休克治疗和未接受电休克治疗个体的特定病因风险比(csHR)。次要结局是非自杀死亡和全因死亡率。
在分析队列中,有67327份精神病住院记录(27231名男性和40096名女性;平均年龄45.1岁[标准差16.8;范围18 - 103]),其中4982人接受了电休克治疗,62345人未接受电休克治疗。没有种族数据。在倾向评分加权分析中,电休克治疗与自杀死亡风险显著降低相关(csHR 0.53[95%置信区间0.31 - 0.92])。将非自杀死亡作为竞争风险进行分析对结果没有影响。电休克治疗还与全因死亡率显著降低相关(0.75[0.58 - 0.97]),但与非自杀死亡无关(0.83[0.61 - 1.12])。
在因抑郁症住院的个体中,电休克治疗与出院后一年内自杀死亡风险显著降低相关。这项研究强化了电休克治疗的重要性,特别是对于重度抑郁症患者。
多伦多大学精神病学系诺里斯学者奖以及加拿大卫生研究院。